USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
14.43
-0.13 (-0.89%)
At close: Sep 3, 2026, 4:00 PM EDT
14.43
0.00 (0.00%)
After-hours: Sep 3, 2026, 4:01 PM EDT

USANA Health Sciences Financials Overview

Millions USD. Fiscal year is Feb - Jan.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Revenue
913.36925.26854.5921.01998.61,186
Revenue Growth
1.57%8.28%-7.22%-7.77%-15.83%4.57%
Gross Profit
707.36724.41693.29744.32804.71968.57
Operating Income
41.4950.8674.5793.07107.61170.19
Net Income
-22.1610.7642.0363.7969.35116.51
Earnings Per Share
-1.210.582.193.303.595.73
EPS Growth
--73.52%-33.64%-8.08%-37.35%-2.22%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Core nutritional
761.14775.45845.79915.21995.041,186
Hiya
121.36131.971.97---
Other
-17.836.745.83.56-
Total
913.36925.26854.5921.01998.61,186

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Cash & Investments
168.56158.38181.77330.42288.42239.83
Total Debt
-31.9639.213.2114.5717.3
Net Cash (Debt)
168.56126.42142.56317.22273.85222.54
Net Cash Growth
11.38%-11.32%-55.06%15.84%23.06%-23.38%
Net Cash Per Share
9.186.817.4416.4014.1810.94

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Operating Cash Flow
27.7322.3560.9970.64103.9121.23
Capital Expenditures
-11.79-13.82-10.07-14.49-10.4-12.76
Free Cash Flow
15.938.5350.9256.1593.5108.46
Free Cash Flow Growth
-68.75%-83.26%-9.31%-39.95%-13.79%-25.36%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Gross Margin
77.45%78.29%81.13%80.81%80.58%81.64%
Operating Margin
4.54%5.50%8.73%10.11%10.78%14.34%
Pretax Margin
0.28%4.49%8.94%11.12%10.88%14.38%
Profit Margin
-2.43%1.16%4.92%6.93%6.94%9.82%
FCF Margin
1.75%0.92%5.96%6.10%9.36%9.14%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
PE Ratio
-33.0316.1816.0714.7316.91
Forward PE
14.1511.1714.3119.8517.0519.17
P/FCF Ratio
16.5741.6813.3618.2610.9318.16
PS Ratio
0.290.380.801.111.021.66